Biomedical HIV prevention tools including oral pre-exposure prophylaxis (PrEP) and vaginal microbicidal rings hold unique value for high-risk women who may have limited capacity for condom negotiation, including the key populations of sex workers and drug users. Commercial sex is a PrEP indicator in CDC guidelines, yet little is known about female sex workers' (FSWs) knowledge of and attitudes toward PrEP or the recently developed monthly vaginal microbicide rings. We describe knowledge and attitudes toward PrEP and microbicide rings in a sample of 60 mostly drug-using FSWs in Baltimore, Maryland, a high HIV-prevalence US city. Just 33% had heard of PrEP, but 65% were interested in taking daily oral PrEP and 76% were interested in a microbicide vaginal ring; 87% were interested in at least one of the two methods. Results suggest method mix will be important as biomedical tools for HIV prophylaxis are implemented and scaled up in this population, as 12% were interested in PrEP but not vaginal rings, while 19% were interested in vaginal rings but not in PrEP. Self-efficacy for daily oral adherence was high (79%) and 78% were interested in using PrEP even if condoms were still necessary. Women who had experienced recent client-perpetrated violence were significantly more interested in PrEP (86% vs 53%, p = 0.009) and microbicidal rings (91% vs 65%, p = 0.028) than women who had not recently experienced violence. No differences were observed by demographics nor HIV risk behaviors, suggesting broad potential interest in daily PrEP and monthly-use vaginal microbicides in this high-risk population.
Introduction
A new generation of biomedical prevention tools holds promise for reducing HIV acquisition among high-risk women. Oral pre-exposure prophylaxis (PrEP) reduces heterosexual HIV acquisition in women by approximately 60%-70% (Baeten et al., 2012; Thigpen et al., 2012) and reduced acquisition among drug-using women by 79% (Choopanya et al., 2013) . A monthly dapivirine-containing vaginal ring, the first longer-acting prophylaxis option for women, was recently shown to reduce infection by 27%-31%, though with variation by age (Baeten, Palanee-Phillips, Brown, Schwartz, et al., 2016; International Partnership for Microbicides, 2016) .
While the efficacy of oral PrEP is established, its realworld effectiveness rests on adherence. Low adherence to daily oral PrEP or microbicides nullified the potential for significant findings in the Fem-PrEP and VOICE trials (Marrazzo et al., 2015; Van Damme et al., 2012) .
Monthly rings obviate the need for daily adherence. However, while levels of adherence were higher in ASPIRE than in VOICE or Fem-PrEP, women sometimes removed the rings, especially younger women, among whom the ring lacked efficacy (Baeten, PalaneePhillips, & Brown, 2016) . Little is known about acceptability of a monthly dapivirine ring among female sex workers (FSWs) .
Key populations in the HIV epidemic, including FSWs (Baral et al., 2012) and drug users (Strathdee & Stockman, 2010) , stand to benefit significantly from pre-exposure prophylaxis. Globally, approximately 15% of women infected are sex workers (Prüss-Ustün et al., 2013) , and an estimated 17% of FSWs in the US are living with HIV (Paz-Baile, Noble, Salo, & Tregear, 2016) . FSWs who use drugs are doubly at risk for acquisition. Modeling suggests that PrEP could reduce HIV incidence in FSWs by 40% (Bekker et al., 2015) .
User-controlled HIV prevention is critical for FSWs, as their HIV risk is shaped by structural factors including limited control over condom usage and violence. Consistent with World Health Organization recommendations (2015), the US Centers for Disease Control and Prevention recommend PrEP for individuals involved in commercial sex (Centers for Disease Control and Prevention, 2014) .
Despite high acceptability of PrEP among FSW internationally (Eisingerich et al., 2012; Van der Elst et al., 2013) , little is known about PrEP and vaginal ring acceptability among FSW in the US. Among mostly drug-using FSWs from Baltimore, Maryland, we describe indicators of awareness of, attitudes toward, and acceptance of oral PrEP and microbicidal rings.
Methods
Data were collected for the INSPIRE study, a feasibility evaluation of a violence prevention and response intervention for FSWs, between March and July 2015. Participants were recruited from two sites of a mobile health service that provides needle exchange and sexual/reproductive health services in Baltimore, Maryland, home to the third-highest HIV incidence of any US city. Eligible female participants were at least 18 years old, had sold or exchanged sex in the past 3 months, and were clients of the city's mobile health services. Of 71 women screened, 66 (66/71, 93.0%) were eligible, and 60 (60/66, 90.9%) consented and enrolled. Women were recruited following their receipt of mobile services and completed a self-administered baseline survey. Participants received a $25 gift card and information for local services.
Survey questions (Table 1 ) measuring knowledge of and attitudes toward oral PrEP and vaginal rings were adapted from published studies (Eaton et al., 2014; Ye et al., 2014 
Results
Women in the sample were largely white (72%) or black (16%), with a mean age of 35.5 years ( Table 2 ). The majority (90%) reported ever injecting drugs.
Only 33% had heard of PrEP, but 65% were somewhat or very interested in taking PrEP when it was described. Four out of five (79%) said it would be somewhat or very easy for them to take a daily pill, 78% said they would take PrEP even if they had to wear condoms for full protection from HIV. There was greater interest in a microbicidal vaginal ring, with three in four women (76%) very or somewhat interested. Of the 52 women who answered both questions, 12% were interested in PrEP but not a microbicidal ring, while 19% were interested in the ring but not PrEP, and 56% indicated interest in both methods. There was high willingness to provide self-collected vaginal swabs and give blood samples for future research studies.
Women who had recently experienced physical or sexual violence from clients were more likely to be interested in PrEP (86% vs 53%, p = 0.009) and microbicidal rings (91% vs 65%, p = 0.028; Table 3 ) than women who had not recently experienced violence. Having a primary female partner and younger age were marginally significant.
Discussion
In some of the first data to explore the acceptability of daily oral PrEP and monthly microbicidal rings among FSWs in the US, this study found strong interest in Table 1 . Survey measures assessing key outcomes and covariates.
Construct Question
Knowledge and awareness HIV Pre-exposure prophylaxis, or PrEP, is a way for people who do not have HIV to prevent HIV infection by taking a pill every day. Have you heard of HIV PrEP before today? Acceptability, PrEP
How interested would you be in taking a pill every day to prevent HIV infection? Acceptability, vaginal ring Researchers are developing a microbicidal (e.g., can kill viruses) vaginal ring that could protect against HIV infection. The ring would be changed monthly. How interested would you be in a microbicidal vaginal ring that could prevent HIV infection? Self-efficacy for adherence How easy would it be for you to take a pill each day, to prevent HIV infection? Potential for risk compensation Would you take PrEP if you still had to use condoms to be fully protected from HIV? Willingness to participate in biomedical research
How willing would you be to provide a self-collected vaginal swab for a research study like this? How willing would you be to provide a blood sample for a research study like this? Physical or sexual violence from clients Have you been hit, punched, slapped or otherwise physically hurt by a client?
Has a client used force (like hitting, holding you down, or using a weapon) to make you have vaginal sex when you didnt want to? Has a client used force (like hitting, holding you down, or using a weapon) to make you have anal sex when you didn't want to? Have you had a client pressure you for, or insist on vaginal sex when you didn't want to (but did not use physical force)? Have you had a client pressure you for, or insist on anal sex when you didn't want to (but did not use physical force)?
these user-controlled prevention tools. Participants were confident that they could use these tools regularly and in conjunction with condoms. Despite low initial awareness of PrEP and microbicidal rings, participants were interested in these tools upon explanation, suggesting that outreach and education may increase demand for these relatively low-cost and low-threshold HIV prevention methods. Given the high acceptability of vaginal swabs and blood samples, clinical trials including biomedical monitoring for drug adherence appear feasible in this population. Interventions to promote oral PrEP should be evaluated in high-risk subsets of women, including FSWs. While vaginal rings have not been approved in the US for HIV prevention, they were even more acceptable than daily oral PrEP in our sample; further research should evaluate their efficacy and evaluate interventions to promote adherence among FSWs. Findings also speak to the importance of continuing to develop a variety of user-controlled prevention methods, as 31% of women were only interested in either oral PrEP or the microbicidal ring, but not the other. Just as having a wide variety of contraceptive methods has proven important in making birth control accessible to more women, having a diverse HIV prevention method mix with varied dosing strategies and delivery mechanisms that meet women's diverse needs, including those of FSWs, will prove important (Delany-Moretlwe, Mullick, Eakle, & Rees, 2016) .
Interest in daily PrEP and the monthly microbicidal ring was significantly higher among FSWs who had recently experienced client violence, affirming the value of user-controlled HIV prevention tools to buffer against structural sources of HIV risk, particularly when ability to negotiate condom use may be limited in light of prevalent client violence. Interest did not vary significantly by demographics or HIV risk behavior, suggesting generalized acceptability of PrEP and vaginal rings in this population.
Further work is needed to extend beyond the limitations of our study, which include small sample size, resulting in a lack of power to detect differences that may have been significant, such as greater interest in PrEP among those with recent IPV victimization (75% vs 61%) or greater interest in the ring by those who are not confident refusing condomless sex with clients (82% vs 71%). The demographic makeup of the sample was comparable with that of FSWs who are clients of the needle exchange; however, the study was conducted in only one city and only among FSW receiving city mobile health services, which limits generalizability. FSW clients of the needle exchange may be more interested in HIV prevention such as PrEP relative to FSW who use drugs but who do not use needle exchange services. Future work will benefit from allowing participants more hands-on experience with the ring and pills, including qualitative work incorporating discussion and opportunity for questions, and exploring differences in modality preferences.
Study recruitment was successful at public mobile clinics providing reproductive health and needle exchange services. Such clinics have the potential to serve as a mechanism for identification and referral of high-risk women who could benefit from biomedical HIV prevention tools when they are implemented more broadly. Because the mobile clinic is also staffed by medical professionals, prescription and monitoring of PrEP could potentially occur in conjunction with existing outreach services, bypassing issues of engaging these marginalized women in traditional primary care settings.
Among this sample of largely drug-using FSWs in a US city with a high prevalence of HIV, there was strong acceptability, interest, and self-efficacy in taking daily oral PrEP as well as interest in microbicidal rings for user-controlled HIV prevention. While transactional sex is an indication for PrEP use within CDC guidelines, only a minority of FSWs in this study were aware of PrEP. Efforts to increase access to user-controlled tools through mobile clinic services may be particularly promising in engaging these high-risk women. Our initial evidence on acceptability, interest and perceived self-efficacy in using these prevention tools among US FSW provide a foundation for efforts to support timely expansion of PrEP and microbicidal rings into this population.
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